{
    "output": [
        [
            "Sanofi",
            "ORG",
            "Obtain",
            "right to develop and sell new hemophilia drug",
            "CONCEPT"
        ],
        [
            "Sanofi",
            "ORG",
            "Operate_In",
            "France",
            "GPE"
        ],
        [
            "Alnylam Pharmaceuticals",
            "ORG",
            "Restructuring",
            "partnership with",
            "Sanofi"
        ],
        [
            "Sanofi",
            "ORG",
            "Obtain",
            "global development and commercialization rights to fitusiran",
            "PRODUCT"
        ],
        [
            "Fitusiran",
            "PRODUCT",
            "Treat",
            "people with hemophilia A and B",
            "CONCEPT"
        ],
        [
            "Sanofi Genzyme",
            "ORG",
            "Global commercialization",
            "fitusiran products",
            "PRODUCT"
        ],
        [
            "Alnylam",
            "ORG",
            "Receive",
            "royalties based on net sales of fitusiran products",
            "PRODUCT"
        ],
        [
            "Fitusiran",
            "PRODUCT",
            "Complement",
            "Sanofi Genzyme\u2019s rare hematology portfolio",
            "SECTOR"
        ],
        [
            "Fitusiran",
            "PRODUCT",
            "Bring",
            "innovative new treatment for people living with hemophilia",
            "CONCEPT"
        ],
        [
            "Alnylam",
            "ORG",
            "Obtain",
            "global development and commercialization rights to new treatment of ATTR amyloidosis",
            "PRODUCT"
        ],
        [
            "Alnylam",
            "ORG",
            "Cause",
            "rare disease caused by the build-up of an abnormal protein",
            "CONCEPT"
        ],
        [
            "Sanofi Genzyme",
            "ORG",
            "Sustained interest",
            "strong potential of Alnylam\u2019s portfolio of genetic medicines",
            "CONCEPT"
        ],
        [
            "Sanofi",
            "ORG",
            "Continue to have",
            "right to opt into other Alnylam rare genetic disease programs",
            "CONCEPT"
        ],
        [
            "Sanofi",
            "ORG",
            "Have",
            "right to a global license",
            "CONCEPT"
        ]
    ]
}